Angiodynamic Inc (NASDAQ: ANGO) kicked off on Tuesday, down -6.01% from the previous trading day, before settling in for the closing price of $10.81. Over the past 52 weeks, ANGO has traded in a range of $5.47-$13.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 2.35% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 27.09%. With a float of $38.73 million, this company’s outstanding shares have now reached $40.97 million.
In an organization with 748 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 53.45%, operating margin of -8.99%, and the pretax margin is -14.85%.
Angiodynamic Inc (ANGO) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Angiodynamic Inc is 4.63%, while institutional ownership is 89.56%. The most recent insider transaction that took place on Jan 16 ’25, was worth 49,979. In this transaction SVP Quality and Regulatory of this company sold 4,060 shares at a rate of $12.31, taking the stock ownership to the 41,817 shares. Before that another transaction happened on Jan 16 ’25, when Company’s Officer proposed sale 4,060 for $12.31, making the entire transaction worth $49,979.
Angiodynamic Inc (ANGO) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.09% per share during the next fiscal year.
Angiodynamic Inc (NASDAQ: ANGO) Trading Performance Indicators
Take a look at Angiodynamic Inc’s (ANGO) current performance indicators. Last quarter, stock had a quick ratio of 1.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.02, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Angiodynamic Inc (ANGO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.78 million. That was better than the volume of 0.63 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 21.96%. Additionally, its Average True Range was 0.54.
During the past 100 days, Angiodynamic Inc’s (ANGO) raw stochastic average was set at 36.14%, which indicates a significant increase from 29.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.83% in the past 14 days, which was higher than the 56.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.75, while its 200-day Moving Average is $8.96. However, in the short run, Angiodynamic Inc’s stock first resistance to watch stands at $10.72. Second resistance stands at $11.27. The third major resistance level sits at $11.79. If the price goes on to break the first support level at $9.65, it is likely to go to the next support level at $9.13. Assuming the price breaks the second support level, the third support level stands at $8.58.
Angiodynamic Inc (NASDAQ: ANGO) Key Stats
The company with the Market Capitalisation of 412.57 million has total of 40,607K Shares Outstanding. Its annual sales at the moment are 303,910 K in contrast with the sum of -184,350 K annual income. Company’s last quarter sales were recorded 72,000 K and last quarter income was -4,410 K.
